4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-15-029053
$FOLDCIK 0001178879operating
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:51 PM ET
Size
9.5 KB
Accession
0001209191-15-029053
Insider Transaction Report
Form 4
Kirk John
VP, Regulatory Affairs
Transactions
- Sale
Common stock
2015-03-20$11.51/sh−10,110$116,359→ 50,000 total - Exercise/Conversion
Stock options (right to buy)
2015-03-20−10,110→ 24,890 totalExercise: $6.06From: 2012-06-16Exp: 2021-06-16→ Common stock (10,110 underlying) - Exercise/Conversion
Common stock
2015-03-20$11.51/sh+10,110$116,359→ 60,110 total
Footnotes (3)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
- [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 9:51 PM ET
- Size
- 9.5 KB